UK medicines regulator approves Pfizer’s ‘life-saving’ Covid pill

Paxlovid found to be ‘safe and effective’ at reducing hospitalisation and death among vulnerable adults

UK regulators have approved Pfizer’s “life-saving” antiviral drug Paxlovid, which boasts nearly 90% success in preventing severe illness among vulnerable adults if taken soon after becoming infected with Covid-19.

The Medicines and Healthcare products Regulatory Agency (MHRA) found the oral treatment “to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate Covid-19 infection, who are at an increased risk of developing severe disease”.

Continue reading...